logo
ENTITY

Dogwood Therapeutics (DWTX US)

3
Analysis
Health Care • United States
Dogwood Therapeutics, Inc. operates as a development-stage biotechnology. The Company develops novel therapeutics and sodium channel blocker to treat moderate-to-severe chemotherapy induced neuropathic pain, cancer pain, and other pain indications. Dogwood Therapeutics serves patients in the United States.
more
Company Event • 11 Nov 2024 21:30 • Upcoming
Add To Calendar

Q3 2024

Company Event • 11 Nov 2024 21:30 • Upcoming
Add To Calendar

Q3 2024

Company Event • 07 Oct 2024 20:30 • Latest

M&A Announcement

Company Event • 07 Oct 2024 20:30

M&A Announcement

Company Event • 08 Aug 2024 19:00 • Upcoming
Add To Calendar

Q2 2024

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.39.3

x